Shanghai GM LifeBank

Shanghai GM LifeBank is a biotechnology company based in China that specializes in the development of induced pluripotent stem cell (iPSC) technologies and cell-based therapies. The company focuses on establishing high-standard clinical-grade iPSC banks and leveraging these cells to develop regenerative medicine solutions for life-threatening conditions such as liver failure and metabolic diseases. By integrating advanced gene editing and cell differentiation techniques, Shanghai GM LifeBank aims to provide standardized, off-the-shelf cell therapy products. Their business model encompasses both therapeutic R&D and specialized biobanking services for clinical applications.